✨ Medicines Distribution Consents
NEW ZEALAND GAZETTE, No. 64
27 MARCH 2008
Schedule
Product:
Imigran Recovery
Active Ingredient:
Sumatriptan succinate 70mg equivalent to sumatriptan base 50mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
GlaxoSmithKline (NZ) Limited
Manufacturer:
Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom
Product:
Luxyal Monodose
Active Ingredient:
Sodium hyaluronate 1.5mg/mL
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Pharma Stulln GmbH, Stulln, Germany
Product:
Luxyal
Active Ingredient:
Sodium hyaluronate 1.5mg/mL
Dosage Form:
Eye drops, solution
New Zealand Sponsor:
AFT Pharmaceuticals Limited
Manufacturer:
Tubilux Pharma SpA, Pomezia, Rome, Italy
Product:
Nicotinell TTS 10
Active Ingredient:
Nicotine 17.5mg (7mg/24hr)
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturer:
LTS Lohmann Therapie-Systeme AG, Andernach, Germany
Product:
Nicotinell TTS 20
Active Ingredient:
Nicotine 35mg (14mg/24h)
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturer:
LTS Lohmann Therapie-Systeme AG, Andernach, Germany
Product:
Nicotinell TTS 30
Active Ingredient:
Nicotine 52.5mg (21mg/24h)
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Novartis Consumer Health Australasia Pty Limited (New Zealand)
Manufacturer:
LTS Lohmann Therapie-Systeme AG, Andernach, Germany
Dated this 20th day of March 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2047
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related product set out in the Schedule hereto:
Schedule
Product:
Colgate Max White - Crystal Mint
Active Ingredient:
Sodium fluoride 0.22% w/w
Dosage Form:
Toothpaste
New Zealand Sponsor:
Colgate-Palmolive Limited
Manufacturers:
Colgate-Palmolive Indústria e Comércio LIMITEDA, Osasco, São Paulo, Brazil
Colgate-Palmolive Indústria e Comércio LIMITEDA, São Bernado do Campo, São Paulo, Brazil
Dated this 20th day of March 2008.
JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2048
Renewal of Provisional Consent to the Distribution of New Medicines
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2008, No 64
Gazette.govt.nz —
NZ Gazette 2008, No 64
✨ LLM interpretation of page content
🏥
Consent to the Distribution of New Medicines
(continued from previous page)
🏥 Health & Social Welfare20 March 2008
Medicines Act 1981, New Medicines, Distribution, Schedule
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
🏥 Consent to the Distribution of a New Related Product
🏥 Health & Social Welfare20 March 2008
Medicines Act 1981, New Related Product, Distribution, Toothpaste
- JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate
🏥 Renewal of Provisional Consent to the Distribution of New Medicines
🏥 Health & Social WelfareMedicines Act 1981, Provisional Consent, Distribution, New Medicines